Nuzenio

European Patent Covering

European Patent Covering news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 11 latest news signals 9 publisher sources 100/100 entity strength

Latest news

Silo Pharma Announces European Patent Grant for SPC-15 PTSD Prevention Therapy - Quiver QuantitativeQuiver Quantitative · Mon, 10 Aug 2026 12:20:00 GMT A nasal PTSD treatment is patented for use before extreme stress - Stock TitanStock Titan · Mon, 10 Aug 2026 12:15:00 GMT Silo Pharma Granted European Patent Covering Novel PTSD Therapy - GlobeNewswireGlobeNewswire · Mon, 10 Aug 2026 12:15:00 GMT ValiRx Secures Second European Patent for Cytolytix Cancer-Killing Peptide - Share TalkShare Talk · Mon, 10 Aug 2026 09:39:33 GMT ValiRx set to land second European patent for Cytolytix cancer peptide - proactiveinvestors.comproactiveinvestors.com · Mon, 10 Aug 2026 07:18:00 GMT ValiRx strengthens Cytolytix cancer IP with European patent progress and new filing - Yahoo Finance UKYahoo Finance UK · Mon, 10 Aug 2026 07:00:20 GMT ValiRx (VAL) Subsidiary Cytolytix Set to Secure Second European Patent for Core Anti-Cancer Peptide Technology - Kalkine MediaKalkine Media · Mon, 10 Aug 2026 06:01:17 GMT FibroBiologics Granted European Patent Covering Gene Therapy for the Regeneration of Cartilage - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 12:30:00 GMT

Timeline

Mon, 10 Aug 2026 12:20:00 GMTSilo Pharma Announces European Patent Grant for SPC-15 PTSD Prevention Therapy - Quiver Quantitative

Mon, 10 Aug 2026 12:15:00 GMTA nasal PTSD treatment is patented for use before extreme stress - Stock Titan

Mon, 10 Aug 2026 12:15:00 GMTSilo Pharma Granted European Patent Covering Novel PTSD Therapy - GlobeNewswire

Mon, 10 Aug 2026 09:39:33 GMTValiRx Secures Second European Patent for Cytolytix Cancer-Killing Peptide - Share Talk

Mon, 10 Aug 2026 07:18:00 GMTValiRx set to land second European patent for Cytolytix cancer peptide - proactiveinvestors.com

Mon, 10 Aug 2026 07:00:20 GMTValiRx strengthens Cytolytix cancer IP with European patent progress and new filing - Yahoo Finance UK

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

ValiRx5 live mentions European4 live mentions Cytolytix4 live mentions Patent3 live mentions Yahoo Finance UK3 live mentions SPC2 live mentions PTSD Prevention Therapy2 live mentions PTSD2 live mentions Stock Titan Stock2 live mentions Titan2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for European Patent Covering.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

9 distinct publisher/source names are currently connected to this entity page.